Literature DB >> 9329068

Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test.

S E File1.   

Abstract

CGP 49823, a substance P antagonist acting at NK1 receptors, had significant anxiolytic effects at 3, 10 and 30 mg/kg orally in the high-light unfamiliar and low-light unfamiliar conditions of the social interaction test but was without effect in the low-light familiar condition. The effects were less marked after 3 and 6 weeks of treatment (10 mg/kg/day), indicating that some tolerance had developed, but a significant anxiolytic effect still remained. After 3 weeks of diazepam treatment (2 mg/kg/day, intraperitoneally), tolerance developed to the anxiolytic effects, and there was an anxiogenic response 24 h after withdrawal. In contrast, there were no anxiogenic withdrawal effects 24 h after 3 weeks or 24, 48 or 72 h after 6 weeks treatment with CGP 49823 (10 mg/kg/day). These results suggest that the compound may prove to be a useful anxiolytic and that substance P may play a role in mediating states of anxiety.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9329068     DOI: 10.1016/s0091-3057(97)90002-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  16 in total

Review 1.  Translational and reverse translational research on the role of stress in drug craving and relapse.

Authors:  Rajita Sinha; Yavin Shaham; Markus Heilig
Journal:  Psychopharmacology (Berl)       Date:  2011-04-15       Impact factor: 4.530

2.  A pharmacophore model for NK2 antagonist comprising compounds from several structurally diverse classes.

Authors:  Anders Poulsen; Tommy Liljefors; Klaus Gundertofte; Berith Bjørnholm
Journal:  J Comput Aided Mol Des       Date:  2002-04       Impact factor: 3.686

3.  Corticotropin-releasing factor mRNA and substance P receptor binding in the paraventricular hypothalamic nucleus, central nucleus of the amygdala, and locus coeruleus of Sprague-Dawley rats following restraint-induced stress.

Authors:  Bang H Hwang; Jason Katner; Smriti Iyengar
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

4.  Neurokinin-1 receptors (NK1R:s), alcohol consumption, and alcohol reward in mice.

Authors:  Annika Thorsell; Jesse R Schank; Erick Singley; Stephen P Hunt; Markus Heilig
Journal:  Psychopharmacology (Berl)       Date:  2010-01-30       Impact factor: 4.530

5.  Cellular and behavioral outcomes of dorsal striatonigral neuron ablation: new insights into striatal functions.

Authors:  Delphine Révy; Florence Jaouen; Pascal Salin; Christophe Melon; Dorian Chabbert; Elisiana Tafi; Lena Concetta; Francina Langa; Marianne Amalric; Lydia Kerkerian-Le Goff; Hélène Marie; Corinne Beurrier
Journal:  Neuropsychopharmacology       Date:  2014-06-06       Impact factor: 7.853

6.  Evaluation of the anxiolytic-like effect of NKP608, a NK1-receptor antagonist, in two rat strains that differ in anxiety-related behaviors.

Authors:  Leandro F Vendruscolo; Reinaldo N Takahashi; Gustavo R Brüske; André Ramos
Journal:  Psychopharmacology (Berl)       Date:  2003-08-12       Impact factor: 4.530

Review 7.  Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues.

Authors:  Markus Heilig; Annika Thorsell; Wolfgang H Sommer; Anita C Hansson; Vijay A Ramchandani; David T George; Daniel Hommer; Christina S Barr
Journal:  Neurosci Biobehav Rev       Date:  2009-11-24       Impact factor: 8.989

Review 8.  Criteria for validating mouse models of psychiatric diseases.

Authors:  Kathryn K Chadman; Mu Yang; Jacqueline N Crawley
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-01-05       Impact factor: 3.568

9.  Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils.

Authors:  Scott A Heldt; Michael Davis; Emiliangelo Ratti; Mauro Corsi; David Trist; Kerry J Ressler
Journal:  Behav Pharmacol       Date:  2009-10       Impact factor: 2.293

10.  Optogenetic examination identifies a context-specific role for orexins/hypocretins in anxiety-related behavior.

Authors:  W Heydendael; A Sengupta; S Beck; S Bhatnagar
Journal:  Physiol Behav       Date:  2013-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.